VEGFA and nasopharyngeal carcinoma: A previous study found that vascular endothelial growth factor (VEGF) was overexpressed in most (> 60%) clinical biopsy specimens of NPC.(9) Apatinib is a new tyrosine kinase inhibitor for VEGFR-2.